104 related articles for article (PubMed ID: 1494454)
1. The breakdown and utilization of peptides by strains of Fusobacterium nucleatum.
Rogers AH; Gully NJ; Pfennig AL; Zilm PS
Oral Microbiol Immunol; 1992 Oct; 7(5):299-303. PubMed ID: 1494454
[TBL] [Abstract][Full Text] [Related]
2. Measurement of electrical bioimpedance for studying utilization of amino acids and peptides by Porphyromonas gingivalis, Fusobacterium nucleatum, and Treponema denticola.
Shah HN; Gharbia SE; Zhang MI
Clin Infect Dis; 1993 Jun; 16 Suppl 4():S404-7. PubMed ID: 8391864
[TBL] [Abstract][Full Text] [Related]
3. Dipeptide utilization by the periodontal pathogens Porphyromonas gingivalis, Prevotella intermedia, Prevotella nigrescens and Fusobacterium nucleatum.
Takahashi N; Sato T
Oral Microbiol Immunol; 2002 Feb; 17(1):50-4. PubMed ID: 11860556
[TBL] [Abstract][Full Text] [Related]
4. Studies on fusobacteria associated with periodontal diseases.
Rogers AH
Aust Dent J; 1998 Apr; 43(2):105-9. PubMed ID: 9612984
[TBL] [Abstract][Full Text] [Related]
5. Changes in growth and polyglucose synthesis in response to fructose metabolism by Fusobacterium nucleatum grown in continuous culture.
Zilm PS; Gully NJ; Rogers AH
Oral Microbiol Immunol; 2003 Aug; 18(4):260-2. PubMed ID: 12823803
[TBL] [Abstract][Full Text] [Related]
6. Growth pH and transient increases in amino acid availability influence polyglucose synthesis by Fusobacterium nucleatum grown in continuous culture.
Zilm PS; Gully NJ; Rogers AH
FEMS Microbiol Lett; 2002 Oct; 215(2):203-8. PubMed ID: 12399036
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the amino acid uptake profile of reference and clinical isolates of Fusobacterium nucleatum subspecies.
Gharbia SE; Shah HN
Oral Microbiol Immunol; 1991 Oct; 6(5):264-9. PubMed ID: 1820562
[TBL] [Abstract][Full Text] [Related]
8. Utilization of amino acids and peptides by Fusobacterium nucleatum.
Bakken V; Högh BT; Jensen HB
Scand J Dent Res; 1989 Feb; 97(1):43-53. PubMed ID: 2565597
[TBL] [Abstract][Full Text] [Related]
9. Acid-neutralizing activity during amino acid fermentation by Porphyromonas gingivalis, Prevotella intermedia and Fusobacterium nucleatum.
Takahashi N
Oral Microbiol Immunol; 2003 Apr; 18(2):109-13. PubMed ID: 12654101
[TBL] [Abstract][Full Text] [Related]
10. Utilization of D-amino acids by Fusobacterium nucleatum and Fusobacterium varium.
Ramezani M; MacIntosh SE; White RL
Amino Acids; 1999; 17(2):185-93. PubMed ID: 10524276
[TBL] [Abstract][Full Text] [Related]
11. Competition for peptides and amino acids among periodontal bacteria.
Tang-Larsen J; Claesson R; Edlund MB; Carlsson J
J Periodontal Res; 1995 Nov; 30(6):390-5. PubMed ID: 8544102
[TBL] [Abstract][Full Text] [Related]
12. Quantitative proteomic analysis of extracellular matrix extracted from mono- and dual-species biofilms of Fusobacterium nucleatum and Porphyromonas gingivalis.
Mohammed MMA; Pettersen VK; Nerland AH; Wiker HG; Bakken V
Anaerobe; 2017 Apr; 44():133-142. PubMed ID: 28285095
[TBL] [Abstract][Full Text] [Related]
13. Genome sequence of Fusobacterium nucleatum subspecies polymorphum - a genetically tractable fusobacterium.
Karpathy SE; Qin X; Gioia J; Jiang H; Liu Y; Petrosino JF; Yerrapragada S; Fox GE; Haake SK; Weinstock GM; Highlander SK
PLoS One; 2007 Aug; 2(7):e659. PubMed ID: 17668047
[TBL] [Abstract][Full Text] [Related]
14. NOX1/2 activation in human gingival fibroblasts by Fusobacterium nucleatum facilitates attachment of Porphyromonas gingivalis.
Ahn SH; Song JE; Kim S; Cho SH; Lim YK; Kook JK; Kook MS; Lee TH
Arch Microbiol; 2016 Aug; 198(6):573-83. PubMed ID: 27071620
[TBL] [Abstract][Full Text] [Related]
15. Fusobacterium nucleatum involvement in adult periodontitis and possible modification of strain classification.
Roques CG; El kaddouri S; Barthet P; Duffort JF; Arellano M
J Periodontol; 2000 Jul; 71(7):1144-50. PubMed ID: 10960022
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of a novel adhesin unique to oral fusobacteria.
Han YW; Ikegami A; Rajanna C; Kawsar HI; Zhou Y; Li M; Sojar HT; Genco RJ; Kuramitsu HK; Deng CX
J Bacteriol; 2005 Aug; 187(15):5330-40. PubMed ID: 16030227
[TBL] [Abstract][Full Text] [Related]
17. Amino acid utilization by Fusobacterium nucleatum grown in a chemically defined medium.
Dzink JL; Socransky SS
Oral Microbiol Immunol; 1990 Jun; 5(3):172-4. PubMed ID: 2080074
[TBL] [Abstract][Full Text] [Related]
18. Increased proliferation and decreased membrane permeability as defense mechanisms of Fusobacterium nucleatum against human neutrophilic peptide-1.
Keskin M; Könönen E; Söderling E; Isik G; Firatli E; Uitto VJ; Gürsoy UK
Anaerobe; 2014 Dec; 30():35-40. PubMed ID: 25132418
[TBL] [Abstract][Full Text] [Related]
19. Active domains of salivary statherin on apatitic surfaces for binding to Fusobacterium nucleatum cells.
Sekine S; Kataoka K; Tanaka M; Nagata H; Kawakami T; Akaji K; Aimoto S; Shizukuishi S
Microbiology (Reading); 2004 Jul; 150(Pt 7):2373-2379. PubMed ID: 15256578
[TBL] [Abstract][Full Text] [Related]
20. Veillonella Catalase Protects the Growth of Fusobacterium nucleatum in Microaerophilic and Streptococcus gordonii-Resident Environments.
Zhou P; Li X; Huang IH; Qi F
Appl Environ Microbiol; 2017 Oct; 83(19):. PubMed ID: 28778894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
